Clinical Trials on Vin II

Total 10741 results

Ain Shams University

Recruiting

Evaluation of Clinical Success of Bulk Fil Composite Versus Highly Viscous Glass Ionomer in Primary Class II Molars

Dental Caries Class II

Egypt
Ain Shams University

Recruiting

Clinical Performance of Two Different Restorative Materials in Restoring Class II Cavities of Primary Molars

Dental Caries Class II

Egypt
Hacettepe University

Active, not recruiting

Comparison of Bulk-Fill Composite Resins in Class II Restorations

Class II Dental Caries

Turkey
Nourhan M.Aly

Completed

Comparative Clinical Evaluation Between a Novel Self Adhesive and Conventional Bulk-fill Composites

Class II Dental Caries

Egypt
Cairo University

Active, not recruiting

Clinical Evaluation of Self- Adhesive Bulk-fill Resin Composite Versus Conventionally Bonded Bulk-fill Resin Composite in Restoration of Proximal Lesions

Dental Caries Class II

Egypt
Cairo University

Completed

Influence of Lateral Pressure on Sectional Matrix

Class II Dental Caries

Egypt
Piazza della Vittoria 14 Studio Medico - Ginecologia...

Completed

Knowledge and Perspective of Healthcare Professionals About Female Genital Mutation (FMG-HCPROF)

Female Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III Status

Italy
University of Southern California
National Cancer Institute (NCI)

Completed

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

Stage II Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma In Situ

United States
Mental Health Services in the Capital Region, Denmark

Recruiting

Lithium Versus Lamotrigine in Bipolar Disorder, Type II (LiLa-Bipolar)

Bipolar II Disorder

Denmark
Cairo University

Not yet recruiting

Evaluation of Performance and Occlusal Wear of Low Shrinkage Giomer Compared to Nanohybrid Resin Composite

Caries Class II
Cairo University

Recruiting

Clinical Performance of Short Fiber Reinforced Flowable Resin Composite Restorations 2y RCT

Caries Class II | Decay, Dental

Egypt
University of Alberta, Graduate Orthodontic Program

Unknown

Study the Effect of Upper Expansion Appliances on Lower Jaw Forward Projection/Growth

Overbite (Excessive) Horizontal
Takeda

Completed

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Grade I or II Essential Hypertension

Japan
Medical College of Wisconsin
Medical University of South Carolina

Completed

Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST) (FITEST)

Diabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type II

United States
Damascus University

Completed

Patient Outcomes Associated With Two Accelerated Method of Retraction of Upper Front Teeth

Class II Division 1 Malocclusion

Syrian Arab Republic
Firstkind Ltd

Completed

Firefly ANKLE Sprain Study

Grade I/II Ankle Sprain

United Kingdom
Genzyme, a Sanofi Company

Terminated

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Glycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)

United States, Taiwan, Germany
Genzyme, a Sanofi Company

Completed

Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa

Glycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)

United States, Netherlands, United Kingdom, Germany
Genzyme, a Sanofi Company

Completed

Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme®

Glycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)

France
National Cancer Institute (NCI)

Completed

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Glioma | Glioblastoma Multiforme | Giant Cell Glioblastoma | Oligodendrogliomas | Astrocytoma, Grades II, III and IV

United States
Oregon State University
Sanofi

Completed

Empowering Patients to Better Manage Diabetes Through Self-Care

Type I or Type II Diabetes (Excludes Gestational Diabetes)
Genzyme, a Sanofi Company

Approved for marketing

Alglucosidase Alfa Temporary Access Program (ATAP)

Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)

United States
LVD Biotech S.L

Active, not recruiting

Safety and Efficacy Of Amber Peripheral Liquid Embolic System (OPAL)

Hemorrhage | Varicose Veins | Aneurysm | Vascular Anomalies | Pseudoaneurysm | Portal Vein Embolization | Hypervascular Tumor | Type II Endoleak | Pathological Organ

Spain
Cairo University

Recruiting

Effects of Modified Fixed Twin Block Versus Removable Twin Block on Skeletal Class 2 Growing Patients With Mandibular Deficiency

Malocclusion | Angle Class II | Mandible Small

Egypt
Frank Lieberman
University of Minnesota

Completed

Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas

High Risk WHO Grade II Glioma | Recurrent/Post-Chemotherapy WHO Grade II Glioma

United States
Sivakami A Pai

Unknown

Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.

Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.

United Arab Emirates
University of Texas Southwestern Medical Center

Completed

Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM) (SPrNSM)

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditions

United States
National Cancer Institute (NCI)

Terminated

Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditions

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Acupuncture Pilot Study for Cancer-related Cognitive Function

Gynecologic Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage III Breast Cancer | Stage III Gynecologic Cancer | Stage III Colorectal Cancer | Stage I Colorectal Cancer | Stage II Colorectal Cancer | Stage I Gynecologic... and other conditions

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma

Ann Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann... and other conditions

United States
Genzyme, a Sanofi Company

Recruiting

Pompe Pregnancy Sub-Registry

Pompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Glycogenesis 2 Acid Maltase Deficiency

Croatia, United States, Italy, Belgium, Czechia
Wake Forest University Health Sciences
Orthopaedic Trauma Association; Orthopaedic Research and Education Fund

Completed

A Study of Immediate and Delayed Closure of Type II and IIIa Open Tibia Fractures

Type II and IIa Open Tibia Fractures

United States
Wroclaw Medical University

Completed

Photobiomodulation of Orthodontic Mini-implants by a 635nm Diode Laser

Malocclusion, Angle Class II

Poland
Arbeitsgemeinschaft medikamentoese Tumortherapie
Amgen

Terminated

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

KRAS Wild Type | Resectable Type II Gastric Adenocarcinoma

Austria
Rigshospitalet, Denmark
Groupe Hospitalier Pitie-Salpetriere

Completed

Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects (Bezafibrate)

Carnitine Palmitoyltransferase II Deficiency | Very Long Chain Acyl Coa Dehydrogenase Deficiency

Denmark
Massachusetts General Hospital
Brigham and Women's Hospital; Abbott Medical Devices

Completed

Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy (DIRECT)

Wide QRS Complex | Heart Failure - NYHA II - IV

United States
Visnja Katic
University of Rijeka; Clinical Hospital Center Rijeka

Completed

Predictors Associated With Seeking Orthodontic Treatment, Compliance and Treatment Success (PONCOS)

Malocclusion, Angle Class II

Croatia
Damascus University

Completed

Evaluation of the Levels of Pain and Discomfort Associated With Two Techniques of Corticotomy

Class II Division 1 Malocclusion

Syrian Arab Republic
Jordan University of Science and Technology
University of Edinburgh; University of Sydney

Completed

The Rate of Space Closure With Piezocision-based Corticotomy in Different Facial Types: A Split-mouth Design (RCT)

Class II Div 1 Malocclusion

Jordan
Cedars-Sinai Medical Center

Recruiting

Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies

Prostate Cancer Stage II | Prostate Cancer Stage I | Bladder Cancer Stage II | Kidney Cancer Stage I

United States
Centre Hospitalier Universitaire, Amiens
Merck Serono International SA

Completed

May Metformin be Used in Renal Failure?

Renal Disorder Associated With Type II Diabetes Mellitus

France
Fred Hutchinson Cancer Center

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Primary Myelofibrosis | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated... and other conditions

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD (DM+PAD)

Peripheral Arterial Disease | Type II Diabetes Mellitus

United States
University of Nebraska
National Cancer Institute (NCI)

Terminated

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States
Rawda Hesham Abd ElAziz

Recruiting

Clinical Performance of Advanced Self- Adhesivee Resin Composite Hybrid Restorations.

Caries,Dental | Caries Class II

Egypt
Eastern Cooperative Oncology Group

Completed

Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer

Stage I-II Head and Neck Cancer
Sichuan Academy of Medical Sciences

Unknown

Metabolomics Dynamics Study for Severe Patient

Age:18-70 Years | Acute Severe Disease | Acute Physiology And Chronic Health Evaluation(APACHE)II>10

China
Maggie's Pearl, LLC

Active, not recruiting

Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG

Pmm2-CDG | Phosphomannomutase 2 Deficiency | Phosphomannomutase 2 Congenital Disorder of Glycosylation | Phosphomannomutase II Congenital Disorder of Glycosylation | Phosphomannomutase II Deficiency

United States
Damascus University

Completed

Laser-assisted Flapless Corticotomy in Accelerating Canine Retraction

Class II Division 1 Malocclusion | Protrusion, Incisor | Maxillary Prognathism

Syrian Arab Republic
Endotronix, Inc.

Recruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Heart Failure NYHA Class II | Heart Failure NYHA Class III

United States

Clinical Trials on Vin II

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations